• UroGen Pharma's (URGN) Buy Rating Reaffirmed at D. Boral Capital

    Source: Buzz FX / 13 Feb 2025 10:01:11   America/Chicago


    UroGen Pharma's (URGN) Buy Rating Reaffirmed at D. Boral Capital Written by MarketBeat February 13, 2025 Share Link copied to clipboard. UroGen Pharma ( NASDAQ:URGN - Get Free Report ) 's stock had its "buy" rating restated by investment an
    Read more...
Share on,